Andrew N Schiff - Net Worth and Insider Trading

Andrew N Schiff Net Worth

The estimated net worth of Andrew N Schiff is at least $93 Million dollars as of 2024-11-29. Andrew N Schiff is the Director of ZELTIQ Aesthetics Inc and owns about 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $91 Million. Andrew N Schiff is also the Director of Aclaris Therapeutics Inc and owns about 434,455 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $2 Million. Details can be seen in Andrew N Schiff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew N Schiff has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew N Schiff

To

Andrew N Schiff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew N Schiff owns 18 companies in total, including Aclaris Therapeutics Inc (ACRS) , Zosano Pharma Corp (ZSANQ) , and Sunesis Pharmaceuticals Inc (SNSS) among others .

Click here to see the complete history of Andrew N Schiff’s form 4 insider trades.

Insider Ownership Summary of Andrew N Schiff

Ticker Comapny Transaction Date Type of Owner
ACRS Aclaris Therapeutics Inc 2022-11-14 director
ZSANQ Zosano Pharma Corp 2019-04-11 10 percent owner
SNSS Sunesis Pharmaceuticals Inc 2019-07-15 10 percent owner
LIMIT LIMIT 2018-07-10 10 percent owner
LIMIT LIMIT 2017-04-28 director & 10 percent owner
LIMIT LIMIT 2016-06-29 10 percent owner
LIMIT LIMIT 2014-05-23 10 percent owner
LIMIT LIMIT 2016-03-30 10 percent owner
LIMIT LIMIT 2013-12-06 director & 10 percent owner
LIMIT LIMIT 2015-12-09 10 percent owner
LIMIT LIMIT 2015-04-23 10 percent owner
LIMIT LIMIT 2015-04-14 10 percent owner
LIMIT LIMIT 2015-01-27 10 percent owner
LIMIT LIMIT 2012-02-13 10 percent owner
LIMIT LIMIT 2012-02-07 10 percent owner
LIMIT LIMIT 2019-01-23 10 percent owner
LIMIT LIMIT 2021-06-24 other: Managing Member
LIMIT LIMIT 2021-06-23 director

Andrew N Schiff Latest Holdings Summary

Andrew N Schiff currently owns a total of 2 stocks. Among these stocks, Andrew N Schiff owns 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of August 11, 2016, with a value of $91 Million and a weighting of 98.21%. Andrew N Schiff also owns 434,455 shares of Aclaris Therapeutics Inc (ACRS) as of November 14, 2022, with a value of $2 Million and a weighting of 1.79%.

Latest Holdings of Andrew N Schiff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZLTQ ZELTIQ Aesthetics Inc 2016-08-11 1,610,879 56.48 90,982,446
ACRS Aclaris Therapeutics Inc 2022-11-14 434,455 3.82 1,659,618

Holding Weightings of Andrew N Schiff


Andrew N Schiff Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew N Schiff has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 500,000 shares on August 11, 2016, which brought Andrew N Schiff around $18 Million.

According to the SEC Form 4 filings, Andrew N Schiff has made a total of 6 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 53,926 shares on November 14, 2022, which brought Andrew N Schiff around $919,438.

Insider Trading History of Andrew N Schiff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew N Schiff Trading Performance

GuruFocus tracks the stock performance after each of Andrew N Schiff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew N Schiff is -20.99%. GuruFocus also compares Andrew N Schiff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew N Schiff within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew N Schiff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew N Schiff

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.24 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew N Schiff Ownership Network

Ownership Network List of Andrew N Schiff

No Data

Ownership Network Relation of Andrew N Schiff

Insider Network Chart

Andrew N Schiff Owned Company Details

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Andrew N Schiff is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Andrew N Schiff made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 666,666 shares made by Anand Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 666,666 shares, with a net purchase of 666,666 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 5,544,913 shares were bought by its insiders, resulting in a net purchase of 5,526,913 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aclaris Therapeutics Inc Insider Transactions

No Available Data

Andrew N Schiff Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew N Schiff. You might contact Andrew N Schiff via mailing address: Planet Zanett Inc, 135 E 57th St, New York Ny 10022.

Discussions on Andrew N Schiff

No discussions yet.